Page last updated: 2024-11-04

sulfisoxazole and Hypertrophy, Right Ventricular

sulfisoxazole has been researched along with Hypertrophy, Right Ventricular in 1 studies

Sulfisoxazole: A short-acting sulfonamide antibacterial with activity against a wide range of gram- negative and gram-positive organisms.
sulfisoxazole : A sulfonamide antibacterial with an oxazole substituent. It has antibiotic activity against a wide range of gram-negative and gram-positive organisms.

Hypertrophy, Right Ventricular: Enlargement of the RIGHT VENTRICLE of the heart. This increase in ventricular mass is often attributed to PULMONARY HYPERTENSION and is a contributor to cardiovascular morbidity and mortality.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Uchino, T1
Sanyal, SN1
Yamabe, M1
Kaku, T1
Takebayashi, S1
Shimaoka, T1
Shimada, T1
Noguchi, T1
Ono, K1

Other Studies

1 other study available for sulfisoxazole and Hypertrophy, Right Ventricular

ArticleYear
Rescue of pulmonary hypertension with an oral sulfonamide antibiotic sulfisoxazole by endothelin receptor antagonistic actions.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2008, Volume: 31, Issue:9

    Topics: Administration, Oral; Animals; Anti-Infective Agents; Atrial Natriuretic Factor; Blood Pressure; Dis

2008